BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 2, 2002
View Archived Issues
Novel calcium receptor modulators and their use described in Aventis patent
Read More
Two Shionogi patents describe novel immunosuppressant agents
Read More
Merck reports development of inhibitors of p38 kinase
Read More
Novel cytokine and T-cell production inhibitors and their use in cancer, arthritis, etc.
Read More
KN-62 inhibits MAPK/c-Myc activation and proliferation in human keratinocytes
Read More
NO-1886 combined with exercise may prevent development of atherosclerosis in the elderly
Read More
The antifungal clotrimazole exhibits neuroprotective effects in vitro
Read More
PARP inhibitor GPI-6150 effective in rat model of colitis
Read More
Antiamnesic effects of DM-232 demonstrated in mice and rats
Read More
Efficacy of IS-741 on spontaneous colitis in transgenic rat model
Read More
New inhibitors of malonyl-CoA decarboxylase and their use in heart failure, diabetes, obesity, etc.
Read More
Vical updates progress of Leuvectin program
Read More
Enrollment completed in DIAMOND and SILVER ALT-711 trials
Read More
Extended-spectrum oxazolidinone selected for clinical development
Read More
INS-37217, a next-generation P2Y2 agonist with an enhanced duration of action
Read More
Phase III data in immunocompromised patient population presented for micafungin
Read More
Positive results emerge from pilot trial of SCV-07 in tuberculosis
Read More
Polyphenon enters pivotal phase III trial for genital warts
Read More
Idec gains license to develop HMN-214
Read More
IND cleared for Alzhemed phase II
Read More
Orphan drug grant for Endostatin trial
Read More
Clinical efficacy and safety of ACH-126443 in HBV demonstrated in phase I/II clinical trial
Read More
InterMune and Array BioPharma collaborate on hepatitis drug discovery
Read More
Twelve-month data show efficacy of anecortave acetate in wet AMD
Read More
Iseganan fails to meet primary endpoint in ulcerative oral mucositis phase III trial
Read More
deCODE and Merck & Co. form obesity alliance
Read More
Triangle's Coviracil outperforms Zerit in phase III trial
Read More